Stephen Zoog, Ph.D., joined BioMarin in 2012 and serves as Vice President of Translational Sciences & Center of Technology. In this role, Dr. Zoog leads the strategy and transition of BioMarin’s lead candidates from research into early development and through registration for programs in rare genetic diseases. He oversees six departments focused on non-clinical pharmacology/toxicology, clinical pharmacology, immunogenicity, bioanalytical/in vitro diagnostics, core labs and Translational Sciences Operations. Together, these functions plan and conduct IND-enabling nonclinical strategy, and support design and analysis of translational endpoints for all clinical trials. From 2014 to 2020, Dr. Zoog served as Head of Bioanalytical Sciences.
Learn more about Stephen here: https://www.biomarin.com/our-science/our-scientists/stephen-zoog/
Source BioMarin Pharmaceutical YouTube
